Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - GROSS PROFIT
Gross Profit NTLA - Intellia Therapeutics, Inc.
27.3 M
LAST VALUE
2.15%
2 YEAR CAGR
19.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR